ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025
Recruiting Diverse Prostate Cancer Survivors in Health Outcomes Research: Lessons Learned from Survey and Biospecimen Collection.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
backgroundAddressing disparities in prostate cancer requires inclusive research that recruits racially and ethnically diverse participants. This article describes the recruitment procedures and participant characteristics of a biospecimen-based study involving African American (AA), Hispanic, and non-Hispanic White (NHW) prostate cancer survivors.
methodsAA participants were recruited through an existing biobank, whereas Hispanic and NHW participants were recruited from Moffitt Cancer Center and the University of Miami. Eligible survivors were approached via mail/phone/in person. Consented participants completed paper or electronic patient-reported outcomes measures (English or Spanish) and provided a saliva sample. Recruitment outcomes and participant characteristics were summarized by racial/ethnic group. Genetic ancestry was estimated using admixture analyses based on the 1000 Genomes Project.
resultsOf the 1,862 survivors approached, 648 (35%) consented. Consent rates were highest among AA (56%), followed by NHW (37%) and Hispanic (20%) participants. Among those enrolled, 632 participants (mean age = 64 at diagnosis) completed surveys and self-identified as AA (n = 251), Hispanic (n = 130), or NHW (n = 251). Among those who provided saliva samples (n = 567), genetic admixture analysis revealed that AA participants predominantly shared African ancestry [mean (M) = 82%], NHW participants showed mostly European ancestry (M = 95%), and Hispanic participants displayed a heterogeneous mix of European (M = 67%), African (M = 16%), and admixed American (M = 13%) ancestry.
conclusionsOur inclusive recruitment approaches yielded a racially and genetically diverse cohort of prostate cancer survivors. IMPACT: These findings support the feasibility of recruiting diverse populations and integrating self-reported and genomic data to advance research on cancer survivorship disparities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.